June 23, 2003 — Agilent Technologies Inc. has launched a human genome microarray set for drug discovery and disease research, according to a news release.
The Human 1B Oligo Microarray Kit and Agilent’s existing Human 1A kit include more than 36,000 genes and transcripts. Each can be customized by users with proprietary information or newly identified genes. The new microarray focuses on rarer human genes obtained from Incyte Corp.’s LifeSeq Foundation sequence database, the release said.
Agilent also announced that it has released extraction software for its DNA Microarray Scanner. The version 7.1 software can extract data in fewer than 10 minutes per microarray.
Agilent was at 18.81 in late trading Monday, down from 19.06 Friday.